# OnCo record urethral (cancer). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/cancers/urethral/>
  a schema:MedicalCondition ;
  onco:kind "cancer" ;
  schema:identifier "urethral" ;
  schema:name "Urethral cancer"@en ;
  schema:alternateName "Primary urethral carcinoma"@en, "Carcinoma of the urethra"@en ;
  schema:description "Urethral cancer grows in the tube that carries urine out of the body, with fewer than one case per million people a year. With no randomised trials, it is treated by borrowing from bladder, anal or vulvar cancer depending on cell type and location; chemotherapy with radiotherapy before or instead of surgery lets more patients keep their organs."@en ;
  schema:url <https://onco.cc/cancers/urethral/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Urethral_cancer> ;
  schema:citation <https://www.cancer.gov/types/urethral>, <https://uroweb.org/guidelines/primary-urethral-carcinoma> ;
  onco:tag "nci-coverage", "rare", "genitourinary" ;
  onco:related <https://onco.cc/cancers/urothelial/>, <https://onco.cc/cancers/anal/>, <https://onco.cc/cancers/vulvar/>, <https://onco.cc/cancers/penile/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/>, <https://onco.cc/technologies/imrt-igrt/>, <https://onco.cc/technologies/brachytherapy/>, <https://onco.cc/technologies/checkpoint-inhibitor/>, <https://onco.cc/technologies/adc/> ;
  onco:targets <https://onco.cc/targets/pd1/>, <https://onco.cc/targets/nectin4/>, <https://onco.cc/terms/fgfr3/> ;
  onco:drugs <https://onco.cc/drugs/cisplatin/>, <https://onco.cc/drugs/gemcitabine-cisplatin/>, <https://onco.cc/drugs/fluorouracil/>, <https://onco.cc/drugs/mitomycin/>, <https://onco.cc/drugs/enfortumab-vedotin/>, <https://onco.cc/drugs/pembrolizumab/> ;
  onco:pathways <https://onco.cc/pathways/oncogenic-viruses/> ;
  onco:terms <https://onco.cc/terms/hpv-p16/>, <https://onco.cc/terms/chemoradiation/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-rare-cancers/> ;
  onco:pipeline <https://onco.cc/drugs/enfortumab-vedotin/>, <https://onco.cc/drugs/pembrolizumab/> ;
  onco:standardOfCare <https://onco.cc/technologies/brachytherapy/>, <https://onco.cc/drugs/cisplatin/>, <https://onco.cc/drugs/gemcitabine-cisplatin/>, <https://onco.cc/drugs/fluorouracil/>, <https://onco.cc/drugs/mitomycin/>, <https://onco.cc/technologies/imrt-igrt/>, <https://onco.cc/drugs/enfortumab-vedotin/>, <https://onco.cc/drugs/pembrolizumab/>, <https://onco.cc/drugs/gemcitabine-cisplatin/> .